Dr. Greg Fahy
Hailing from California, Dr. Fahy holds a Bachelor of Science degree in Biology from the University of California at Irvine and a Ph.D. from the Medical College of Georgia in Augusta. Dr. Fahy used to be the Head of the Tissue Cryopreservation Section of the Transfusion and Cryopreservation Research Program for the U.S. Naval Medical Research Institute in Bethesda, Maryland, where he developed the original concept of ice blocking agents.
Before his time at 21st Century Medicine, where he currently is Vice President and Chief Scientific Officer, Dr. Fahy pioneered the practical use of cryopreservation by vitrification and invented a computer system to apply this technology to organs at the American Red Cross. He is also the Chief Scientific Officer at Intervene Immune a biotech company researching rejuvenation of the immune system and in particular the thymus.
With over 30 years of experience in cryobiology, Dr. Fahy is considered a world expert in organ cryopreservation by vitrification. He introduced the modern successful approach to vitrification for the cryopreservation process to cryobiology, and also managed to prove that restoration of organ function after cryopreservation is possible.
Dr. Fahy is also a biogerontologist and is the originator and Editor-in-Chief of The Future of Aging: Pathways to Human Life Extension, a multi-authored book about the future of biogerontology.
For 16 years, Dr. Fahy worked as a Director of the American Aging Association and for 6 years as the editor of AGE News, the organization’s newsletter. He currently serves on the editorial boards of Rejuvenation Research and the Open Geriatric Medicine Journal.